Cargando…

Clinical experience of use of percutaneous peripheral arterial cannulation in sick neonates in a developing country

BACKGROUND: Continuous invasive arterial monitoring is necessary in sick neonates needing hemodynamic and ventilatory support. The primary objective of our study was to describe clinical experience with percutaneous peripheral arterial cannulation (PAC) in sick neonates. METHODS: Neonates needing PA...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Sachin, Kaul, Amita, Mishra, Shambhavi, Pawale, Shridhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561947/
https://www.ncbi.nlm.nih.gov/pubmed/34727913
http://dx.doi.org/10.1186/s12887-021-02943-2
_version_ 1784593170912247808
author Shah, Sachin
Kaul, Amita
Mishra, Shambhavi
Pawale, Shridhar
author_facet Shah, Sachin
Kaul, Amita
Mishra, Shambhavi
Pawale, Shridhar
author_sort Shah, Sachin
collection PubMed
description BACKGROUND: Continuous invasive arterial monitoring is necessary in sick neonates needing hemodynamic and ventilatory support. The primary objective of our study was to describe clinical experience with percutaneous peripheral arterial cannulation (PAC) in sick neonates. METHODS: Neonates needing PAC were prospectively enrolled in the study. Inclusion criteria were: neonates needing respiratory support (invasive or non-invasive), neonates requiring vasoactive medications or neonate likely to need more than 5 sampling pricks in 24 h. RESULTS: One hundred eight neonates (93.1%) needed cannulation of one arterial site while 8 (6.9%) needed cannulation of 2 arterial sites, thus giving a total of 124 cannulations. Out of the 124 cannulations, 102 (82%) were performed in first attempt, while 22 (18%) cannulations needed 2 or more attempts. Serious complications like discolouration of digits, blanching of skin or bleeding were seen in 6 (4.9%) cannulations. These resolved after removal of arterial line and no long term consequences were noted. On comparing neonates having radial arterial cannulation(n = 108) with posterior tibial arterial cannulation (n = 16) there was no difference in duration of arterial line between radial artery group (mean, SD 53.30 ± 22.56) and posterior tibial artery group (mean, SD 48.25 ± 27.39). However, more attempts were needed to cannulate post tibial artery (mean, SD 2.25 ± 1.32) as compared to radial artery (mean 1.22 ± 0.789) and this difference was statistically significant (MD -1.02, 95% CI − 1.75 to − 0.30). There was no difference in incidence of serious complications between the radial artery group (3.7%, n = 4) as compared to posterior tibial group (5.5%, n = 1, OR 0.57, 95% CI 0.06–5.51, p = 0.63). CONCLUSIONS: Peripheral arterial cannulation is a safe method for hemodynamic monitoring and blood sampling in sick neonates. Complications can be minimized by diligent monitoring and proactive removal of line if there is damping of tracing.
format Online
Article
Text
id pubmed-8561947
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85619472021-11-03 Clinical experience of use of percutaneous peripheral arterial cannulation in sick neonates in a developing country Shah, Sachin Kaul, Amita Mishra, Shambhavi Pawale, Shridhar BMC Pediatr Research Article BACKGROUND: Continuous invasive arterial monitoring is necessary in sick neonates needing hemodynamic and ventilatory support. The primary objective of our study was to describe clinical experience with percutaneous peripheral arterial cannulation (PAC) in sick neonates. METHODS: Neonates needing PAC were prospectively enrolled in the study. Inclusion criteria were: neonates needing respiratory support (invasive or non-invasive), neonates requiring vasoactive medications or neonate likely to need more than 5 sampling pricks in 24 h. RESULTS: One hundred eight neonates (93.1%) needed cannulation of one arterial site while 8 (6.9%) needed cannulation of 2 arterial sites, thus giving a total of 124 cannulations. Out of the 124 cannulations, 102 (82%) were performed in first attempt, while 22 (18%) cannulations needed 2 or more attempts. Serious complications like discolouration of digits, blanching of skin or bleeding were seen in 6 (4.9%) cannulations. These resolved after removal of arterial line and no long term consequences were noted. On comparing neonates having radial arterial cannulation(n = 108) with posterior tibial arterial cannulation (n = 16) there was no difference in duration of arterial line between radial artery group (mean, SD 53.30 ± 22.56) and posterior tibial artery group (mean, SD 48.25 ± 27.39). However, more attempts were needed to cannulate post tibial artery (mean, SD 2.25 ± 1.32) as compared to radial artery (mean 1.22 ± 0.789) and this difference was statistically significant (MD -1.02, 95% CI − 1.75 to − 0.30). There was no difference in incidence of serious complications between the radial artery group (3.7%, n = 4) as compared to posterior tibial group (5.5%, n = 1, OR 0.57, 95% CI 0.06–5.51, p = 0.63). CONCLUSIONS: Peripheral arterial cannulation is a safe method for hemodynamic monitoring and blood sampling in sick neonates. Complications can be minimized by diligent monitoring and proactive removal of line if there is damping of tracing. BioMed Central 2021-11-02 /pmc/articles/PMC8561947/ /pubmed/34727913 http://dx.doi.org/10.1186/s12887-021-02943-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Shah, Sachin
Kaul, Amita
Mishra, Shambhavi
Pawale, Shridhar
Clinical experience of use of percutaneous peripheral arterial cannulation in sick neonates in a developing country
title Clinical experience of use of percutaneous peripheral arterial cannulation in sick neonates in a developing country
title_full Clinical experience of use of percutaneous peripheral arterial cannulation in sick neonates in a developing country
title_fullStr Clinical experience of use of percutaneous peripheral arterial cannulation in sick neonates in a developing country
title_full_unstemmed Clinical experience of use of percutaneous peripheral arterial cannulation in sick neonates in a developing country
title_short Clinical experience of use of percutaneous peripheral arterial cannulation in sick neonates in a developing country
title_sort clinical experience of use of percutaneous peripheral arterial cannulation in sick neonates in a developing country
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561947/
https://www.ncbi.nlm.nih.gov/pubmed/34727913
http://dx.doi.org/10.1186/s12887-021-02943-2
work_keys_str_mv AT shahsachin clinicalexperienceofuseofpercutaneousperipheralarterialcannulationinsickneonatesinadevelopingcountry
AT kaulamita clinicalexperienceofuseofpercutaneousperipheralarterialcannulationinsickneonatesinadevelopingcountry
AT mishrashambhavi clinicalexperienceofuseofpercutaneousperipheralarterialcannulationinsickneonatesinadevelopingcountry
AT pawaleshridhar clinicalexperienceofuseofpercutaneousperipheralarterialcannulationinsickneonatesinadevelopingcountry